Amarin Corp Plc (AMRN)

[Whalatane]

Rose There is no way IMHO that AMRN knows the results of MITIGATE . They wont know until its presented on the 3rd . Kaiser probably doesn't have the final results yet ...its all in-house so they can adjudicate / clean / chk the data fast and are probably still doing it .

Its important that AMRN be really stand offish on this. The trial design etc is all Kaiser / Dr Bhatt .
What some will be looking for is early indications of event lines confirming R-IT CABG
https://events.bizzabo.com/384552/agenda/session/729192. 31 min in ...event lines beginning to diverge

MITIGATE is basically 2 trials in one ...Vascepa benefit in Covid hospitalization etc risk reduction AND and independent confirmation of R-IT results . This is early data re R-IT confirmation ...but they will be looking for event lines beginning to diverge

Kiwi